Literature DB >> 34310619

Sandfly Fever Sicilian Virus-Leishmania major co-infection modulates innate inflammatory response favoring myeloid cell infections and skin hyperinflammation.

Ellen Heirwegh1, Emily MacLean1, Jinlei He1,2, Shaden Kamhawi3, Selena M Sagan4, Martin Olivier1,4.   

Abstract

BACKGROUND: The leishmaniases are a group of sandfly-transmitted diseases caused by species of the protozoan parasite, Leishmania. With an annual incidence of 1 million cases, 1 billion people living in Leishmania-endemic regions, and nearly 30,000 deaths each year, leishmaniasis is a major global public health concern. While phlebotomine sandflies are well-known as vectors of Leishmania, they are also the vectors of various phleboviruses, including Sandfly Fever Sicilian Virus (SFSV). Cutaneous leishmaniasis (CL), caused by Leishmania major (L. major), among other species, results in development of skin lesions on the infected host. Importantly, there exists much variation in the clinical manifestation between individuals. We propose that phleboviruses, vectored by and found in the same sandfly guts as Leishmania, may be a factor in determining CL severity. It was reported by our group that Leishmania exosomes are released into the gut of the sandfly vector and co-inoculated during blood meals, where they exacerbate CL skin lesions. We hypothesized that, when taking a blood meal, the sandfly vector infects the host with Leishmania parasites and exosomes as well as phleboviruses, and that this viral co-infection results in a modulation of leishmaniasis. METHODOLOGY/PRINCIPAL
FINDINGS: In vitro, we observed modulation by SFSV in MAP kinase signaling as well as in the IRF3 pathway that resulted in a pro-inflammatory phenotype. Additionally, we found that SFSV and L. major co-infection resulted in an exacerbation of leishmaniasis in vivo, and by using endosomal (Toll-like receptor) TLR3, and MAVS knock-out mice, deduced that SFSV's hyperinflammatory effect was TLR3- and MAVS-dependent. Critically, we observed that L. major and SFSV co-infected C57BL/6 mice demonstrated significantly higher parasite burden than mice solely infected with L. major. Furthermore, viral presence increased leukocyte influx in vivo. This influx was accompanied by elevated total extracellular vesicle numbers. Interestingly, L. major displayed higher infectiveness with coincident phleboviral infection compared to L. major infection alone. CONCLUSION/SIGNIFICANCE: Overall our work represents novel findings that contribute towards understanding the causal mechanisms governing cutaneous leishmaniasis pathology. Better comprehension of the potential role of viral co-infection could lead to treatment regimens with enhanced effectiveness.

Entities:  

Year:  2021        PMID: 34310619     DOI: 10.1371/journal.pntd.0009638

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  45 in total

1.  A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

Authors:  Y Belkaid; S Mendez; R Lira; N Kadambi; G Milon; D Sacks
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

3.  TIMP-1 signaling via CD63 triggers granulopoiesis and neutrophilia in mice.

Authors:  Julia Kobuch; Haissi Cui; Barbara Grünwald; Paul Saftig; Percy A Knolle; Achim Krüger
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

Review 4.  Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions.

Authors:  Vanessa Diniz Atayde; Kasra Hassani; Alonso da Silva Lira Filho; Andrezza Raposo Borges; Anupam Adhikari; Caroline Martel; Martin Olivier
Journal:  Cell Immunol       Date:  2016-07-28       Impact factor: 4.868

Review 5.  Phlebotomine sand flies and Leishmania parasites: friends or foes?

Authors:  Shaden Kamhawi
Journal:  Trends Parasitol       Date:  2006-07-14

6.  GP96 is a GARP chaperone and controls regulatory T cell functions.

Authors:  Yongliang Zhang; Bill X Wu; Alessandra Metelli; Jessica E Thaxton; Feng Hong; Saleh Rachidi; Ephraim Ansa-Addo; Shaoli Sun; Chenthamarakshan Vasu; Yi Yang; Bei Liu; Zihai Li
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

7.  UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major.

Authors:  Bruno Luiz Fonseca Schamber-Reis; Patricia M Petritus; Braulia C Caetano; Espiridion R Martinez; Kendi Okuda; Douglas Golenbock; Phillip Scott; Ricardo T Gazzinelli
Journal:  J Biol Chem       Date:  2013-01-16       Impact factor: 5.157

Review 8.  Deception and manipulation: the arms of leishmania, a successful parasite.

Authors:  Pedro Cecílio; Begoña Pérez-Cabezas; Nuno Santarém; Joana Maciel; Vasco Rodrigues; Anabela Cordeiro da Silva
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

9.  NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3.

Authors:  Jennifer Deborah Wuerth; Matthias Habjan; Julia Wulle; Giulio Superti-Furga; Andreas Pichlmair; Friedemann Weber
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

10.  Amazonian Phlebovirus (Bunyaviridae) potentiates the infection of Leishmania (Leishmania) amazonensis: Role of the PKR/IFN1/IL-10 axis.

Authors:  Carolina Torturella Rath; Laila Castro Schnellrath; Clarissa R Damaso; Luciana Barros de Arruda; Pedro Fernando da Costa Vasconcelos; Claudia Gomes; Marcia Dalastra Laurenti; Teresa Cristina Calegari Silva; Áislan de Carvalho Vivarini; Nicolas Fasel; Renata Meirelles Santos Pereira; Ulisses Gazos Lopes
Journal:  PLoS Negl Trop Dis       Date:  2019-06-19
View more
  5 in total

1.  Dissection of the macrophage response towards infection by the Leishmania-viral endosymbiont duo and dynamics of the type I interferon response.

Authors:  Amel Bekkar; Nathalie Isorce; Tiia Snäkä; Stéphanie Claudinot; Chantal Desponds; Dmitry Kopelyanskiy; Florence Prével; Marta Reverte; Ioannis Xenarios; Nicolas Fasel; Filipa Teixeira
Journal:  Front Cell Infect Microbiol       Date:  2022-08-04       Impact factor: 6.073

2.  Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae.

Authors:  Mehrdad Shokouhy; Hamzeh Sarvnaz; Yasaman Taslimi; Mahya Sadat Lajevardi; Sima Habibzadeh; Amir Mizbani; Faezeh Shekari; Mandana Behbahani; Ana Claudia Torrecilhas; Sima Rafati
Journal:  Front Cell Infect Microbiol       Date:  2022-08-03       Impact factor: 6.073

3.  In and out: Leishmania metastasis by hijacking lymphatic system and migrating immune cells.

Authors:  Baijayanti Jha; Marta Reverte; Catherine Ronet; Florence Prevel; Florence D Morgenthaler; Chantal Desponds; Lon-Fye Lye; Katherine L Owens; Leonardo Scarpellino; Lalit Kumar Dubey; Amélie Sabine; Tatiana V Petrova; Sanjiv A Luther; Stephen M Beverley; Nicolas Fasel
Journal:  Front Cell Infect Microbiol       Date:  2022-08-12       Impact factor: 6.073

4.  Endoplasmic Stress Affects the Coinfection of Leishmania Amazonensis and the Phlebovirus (Bunyaviridae) Icoaraci.

Authors:  José V Dos Santos; Patricia F Freixo; Áislan de C Vivarini; Jorge M Medina; Lucio A Caldas; Marcia Attias; Karina L Dias Teixeira; Teresa Cristina C Silva; Ulisses G Lopes
Journal:  Viruses       Date:  2022-09-02       Impact factor: 5.818

5.  Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents.

Authors:  Saida Lachhab; Az-Eddine El Mansouri; Ahmad Mehdi; Indira Dennemont; Johan Neyts; Dirk Jochmans; Graciela Andrei; Robert Snoeck; Yogesh S Sanghvi; Mustapha Ait Ali; Philippe M Loiseau; Hassan B Lazrek
Journal:  Mol Divers       Date:  2022-10-17       Impact factor: 3.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.